MTIP has invested in Cynerio, an Israeli company providing innovative solutions for the security of medical devices and Internet of medical Things (IomT).
The security of everyone’s healthcare data is put at high risk by the increasing number of connected medical devices and the lack of security solutions for healthcare providers.
Cynerio was founded by cybersecurity experts Leon Lerman, CEO, and Daniel Brodie, CTO, to deliver a cybersecurity solution that is 100% designed for healthcare providers, based on the industry’s first technology that thoroughly analyzes the medical workflows in the IoMT ecosystem, to automatically discover all the entities on the network, provide an ongoing healthcare specific risk analysis, accurately detect anomalies and stop threats to prevent service disruption, data theft and compliance violations.
“We are delivering a tailor-made, healthcare driven solution for providers to ensure patient safety and data protection while maintaining operational continuity,” explained Leon Lerman.
“MTIP’s expertise in digital health and their healthcare industry network are key to our development and expansion into new markets”.
Rambam Hospital and Tel Aviv Medical Center (Ichilov) are two of the world’s top healthcare organizations using Cynerio’s technology to protect its sensitive data. The company is now focused on US market development.
Hospitals require a security solution that will protect their systems without being intrusive or aggressive and helping the organization meet HIPAA regulatory requirements.
“The Internet of Medical Things is revolutionizing and opening new horizons in the healthcare industry. Nevertheless, this trend will be sustainable in the future only if the security of such connected ecosystem is rightfully addressed.” said Dr. Christoph Kausch Founding Partner and CEO of MTIP. “We are excited to work with Cynerio, a pioneer in the healthcare cybersecurity market with a solution that precisely answers to one the biggest needs of nowadays healthcare industry.”
Share the Article
SFDR Art. 8 or Art. 9? What’s the difference?
SFDR: getting the terminology right
MTIP participates in Oviva’s new $80m Series C funding
Oviva raises $80 million financing round
MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence
MTIP's new investment in Intelligencia
Private Equity 101: Part one – Glossary
Are you new to the healthtech space?
Leading brands revolutionize care journeys with Lumeon
How Lumeon orchestrates care journey
Trialbee – our hero in patient matching and recruiting for clinical trials
Trialbee - patient matching and recruiting
Digital healthcare: patient-first?
Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital
SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?
New SFDR obligations
MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
First Closing of Fund II
MTIP invests in Koa Health to make mental health treatment more accessible
New investment in Koa Health
MTIP scored fantastic grades in the UNPRI assessment report of 2020
UNPRI Report grades 2020
4 Health VCs Share Their Business Priorities and What is Next
Interview Techtour
TytoCare closes $50 million round as the demand for telehealth accelerates
TytoCare closes new round
The digital healthtech sector is expanding – and so are we!
Two new empolyees start in April
MTIP has sucessfully exited Blueprint Genetics
Blueprint exit January 2020
Whitepaper: A positive prognosis for the future of healthtech
Our first Whitepaper
Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch
Elite Summit 2019
New MTIP investment in Quanta Dialysis Technologies
New investment in Quanta